Fabiani I, Chianca M, Cipolla C, Cardinale D
Nat Rev Cardiol. 2025; .
PMID: 39875555
DOI: 10.1038/s41569-025-01126-1.
Godtfredsen S, Yonis H, Baech J, Al-Hussainy N, Riddersholm S, Kober L
Eur J Haematol. 2024; 114(2):343-352.
PMID: 39501912
PMC: 11707824.
DOI: 10.1111/ejh.14334.
Xie S, Sun Y, Zhao X, Xiao Y, Zhou F, Lin L
Front Pharmacol. 2024; 15:1406247.
PMID: 38989148
PMC: 11234178.
DOI: 10.3389/fphar.2024.1406247.
Berridge B, Pierson J, Pettit S, Stockbridge N
Front Toxicol. 2024; 6:1352783.
PMID: 38590785
PMC: 10999590.
DOI: 10.3389/ftox.2024.1352783.
Leo I, Vidula M, Bisaccia G, Procopio M, Licordari R, Perotto M
J Clin Med. 2023; 12(15).
PMID: 37568347
PMC: 10419705.
DOI: 10.3390/jcm12154945.
Biomimetic Nanozymes Suppressed Ferroptosis to Ameliorate Doxorubicin-Induced Cardiotoxicity via Synergetic Effect of Antioxidant Stress and GPX4 Restoration.
Zhang Y, Liu S, Peng J, Cheng S, Zhang Q, Zhang N
Nutrients. 2023; 15(5).
PMID: 36904089
PMC: 10005374.
DOI: 10.3390/nu15051090.
A Co(III) Complex of 1-Amino-4-hydroxy-9,10-anthraquinone Exhibits Apoptotic Action against MCF-7 Human Breast Cancer Cells.
Banerjee S, Roy S, Dharumadurai D, Perumalsamy B, Thirumurugan R, Das S
ACS Omega. 2022; 7(1):1428-1436.
PMID: 35036804
PMC: 8756448.
DOI: 10.1021/acsomega.1c06125.
Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes.
Park H, Hong Y, Han K, Kim P, An E, Lee J
J Cardiovasc Magn Reson. 2021; 23(1):76.
PMID: 34134713
PMC: 8210390.
DOI: 10.1186/s12968-021-00767-8.
Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic.
Barros-Gomes S, Herrmann J, Mulvagh S, Lerman A, Lin G, Villarraga H
Cardiooncology. 2021; 2(1):5.
PMID: 33530144
PMC: 7837147.
DOI: 10.1186/s40959-016-0014-2.
Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer.
Broberg A, Geisler J, Tuohinen S, Skytta T, Hrafnkelsdottir B, Melgaard Nielsen K
Curr Heart Fail Rep. 2020; 17(6):397-408.
PMID: 32979150
PMC: 7683437.
DOI: 10.1007/s11897-020-00486-8.
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.
Herrmann J
Nat Rev Cardiol. 2020; 17(8):474-502.
PMID: 32231332
PMC: 8782611.
DOI: 10.1038/s41569-020-0348-1.
Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans.
Zeiss C, Gatti D, Toro-Salazar O, Davis C, Lutz C, Spinale F
G3 (Bethesda). 2019; 9(8):2637-2646.
PMID: 31263061
PMC: 6686936.
DOI: 10.1534/g3.119.400232.
Doxorubicin-Induced Cardiomyopathy in Children.
Mancilla T, Iskra B, Aune G
Compr Physiol. 2019; 9(3):905-931.
PMID: 31187890
PMC: 7000168.
DOI: 10.1002/cphy.c180017.
Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle-Specific Ubiquitin Ligase MuRF1.
Willis M, Parry T, Brown D, Mota R, Huang W, Beak J
Circ Heart Fail. 2019; 12(3):e005234.
PMID: 30871347
PMC: 6422170.
DOI: 10.1161/CIRCHEARTFAILURE.118.005234.
1-Amino-4-hydroxy-9,10-anthraquinone - An analogue of anthracycline anticancer drugs, interacts with DNA and induces apoptosis in human MDA-MB-231 breast adinocarcinoma cells: Evaluation of structure-activity relationship using computational,....
Mondal P, Roy S, Loganathan G, Mandal B, Dharumadurai D, Akbarsha M
Biochem Biophys Rep. 2017; 4:312-323.
PMID: 29124219
PMC: 5669404.
DOI: 10.1016/j.bbrep.2015.10.008.
Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging.
Farhad H, Staziaki P, Addison D, Coelho-Filho O, Shah R, Mitchell R
Circ Cardiovasc Imaging. 2016; 9(12).
PMID: 27923796
PMC: 5147427.
DOI: 10.1161/CIRCIMAGING.115.003584.
Cardiac MRI: a Translational Imaging Tool for Characterizing Anthracycline-Induced Myocardial Remodeling.
Nguyen K, Hu P, Ennis D, Shao J, Pham K, Chen J
Curr Oncol Rep. 2016; 18(8):48.
PMID: 27292153
PMC: 6509051.
DOI: 10.1007/s11912-016-0533-x.
Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy.
Min K, Kwon O, Smuder A, Wiggs M, Sollanek K, Christou D
J Physiol. 2015; 593(8):2017-36.
PMID: 25643692
PMC: 4405757.
DOI: 10.1113/jphysiol.2014.286518.
Chemotherapy-induced changes in cardiac capillary permeability measured by fluorescent multiple indicator dilution.
Fernandez-Fernandez A, Carvajal D, Lei T, McGoron A
Ann Biomed Eng. 2014; 42(12):2405-15.
PMID: 25224075
PMC: 4241122.
DOI: 10.1007/s10439-014-1110-9.
Evaluation and management of patients with heart disease and cancer: cardio-oncology.
Herrmann J, Lerman A, Sandhu N, Villarraga H, Mulvagh S, Kohli M
Mayo Clin Proc. 2014; 89(9):1287-306.
PMID: 25192616
PMC: 4258909.
DOI: 10.1016/j.mayocp.2014.05.013.